Pricing Log in Create free account
Friday 6 November 2026 Export PRGO’s income statement to Excel — free account

Perrigo Company plc

PRGO Healthcare Drug Manufacturers Specialty & Generic

Perrigo Company plc’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 2.75% from fiscal 2024.

Revenue
−5.24%
EPS
−494.6%
Free cash flow
+138.5%
Total debt
−9.62%

Quarter to September 2026, against a year earlier

15.66 0.17 −1.07%
Market cap
$2.2B
P/E
0.0×
Fwd P/E
−7.2×
Dividend yield
7.41%
F-score
4/9
Altman Z
−0.08
Beneish M
−3.51
Dividend safety
16/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Perrigo Company plc (PRGO) Current ratio

Alert me on Current ratio

Perrigo Company plc's current ratio at the end of the quarter to 30 September 2026 was 2.4×, down 0.4× from fiscal 2025 (2.8×). Over the past ten years it has ranged from 1.1× (fiscal 2015) to 2.8× (fiscal 2025) — the current reading is the highest in ten years. That is in line with the Drug Manufacturers Specialty & Generic industry median of 2.4× and below the Healthcare sector median of 3.1×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 2.8× 16.20%
FY2024 2.4× 33.09%
FY2023 1.8× (26.88%)
FY2022 2.4× 0.48%
FY2021 2.4× 7.21%
FY2020 2.3× 10.92%
FY2019 2.0× 8.29%
FY2018 1.9× (3.86%)
FY2017 2.0× 28.53%
FY2016 1.5× 39.67%

Quarterly newest first

Period Current ratio Change
Sep 2026 2.4× 1.28%
Jun 2026 2.3× (14.51%)
Mar 2026 2.7× (1.55%)
Dec 2025 2.8× 9.86%
43 more quarters

Against its own ten years

Low 1.1× High 2.8×
Ten-year median 2.0×
Current reading's percentile 100

Current ratio against peers

Company Current ratio
RGC Regencell Bioscience Holdings Limited compare 10.8×
HCM HUTCHMED (China) Limited Sponsored ADR compare 5.6×
TRLV Trulieve Cannabis Corp. compare 5.5×
PBH Prestige Consumer Healthcare Inc. compare 2.9×
ANIP ANI Pharmaceuticals, Inc. compare 2.7×
BCRX BioCryst Pharmaceuticals, Inc. compare 2.7×
PRGO Perrigo Company plc 2.4×
XERS Xeris Biopharma Holdings, Inc. compare 2.2×
ALVO Alvotech compare 1.6×
Drug Manufacturers Specialty & Generic industry median 2.4×
Healthcare sector median 3.1×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on PRGO